CLINICAL_TRIALS
trial_result
· 2026-03-25
Clinical Trial Update: HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 [Phase 2]
Summary
Phase 2 trial of HIV antigen-specific T-cells targeting conserved epitopes (HST-NEETs) for HIV-associated lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catherine Bollard | Conditions: HIV Associated Lymphoma | Phase 2 | Status: COMPLETED